Published August 2018 | Version Accepted Version
Journal Article Open

Recombinantly Expressed Gas Vesicles as Nanoscale Contrast Agents for Ultrasound and Hyperpolarized MRI

  • 1. ROR icon California Institute of Technology
  • 2. ROR icon Leibniz-Forschungsinstitut für Molekulare Pharmakologie

Abstract

Ultrasound and hyperpolarized magnetic resonance imaging enable the visualization of biological processes in deep tissues. However, few molecular contrast agents are available to connect these modalities to specific aspects of biological function. We recently discovered that a unique class of gas‐filled protein nanostructures known as gas vesicles could serve as nanoscale molecular reporters for these modalities. However, the need to produce these nanostructures via expression in specialized cultures of cyanobacteria or haloarchaea limits their broader adoption by other laboratories and hinders genetic engineering of their properties. Here, we describe recombinant expression and purification of Bacillus megaterium gas vesicles using a common laboratory strain of Escherichia coli, and characterize the physical, acoustic, and magnetic resonance properties of these nanostructures. Recombinantly expressed gas vesicles produce ultrasound and hyperpolarized ^(129)Xe MRI contrast at subnanomolar concentrations, thus validating a simple platform for their production and engineering.

Additional Information

© 2018 American Institute of Chemical Engineers. Issue Online: 25 July 2018; Version of Record online: 08 March 2018; Accepted manuscript online: 23 February 2018; Manuscript revised: 07 February 2018; Manuscript received: 10 November 2017. This research was supported by the NIH (R01-EB018975 to MGS) and HFSP (RGP0050 to MGS and LS). A.L. is supported by the NSF graduate research fellowship (award number 1144469) and the NIH Biotechnology Leaders Program. A.F. is supported by the NSERC graduate fellowship. Related work in the Shapiro Lab is also supported by the Heritage Medical Research Institute, the Pew Charitable Trust, the Sontag Foundation, the Burroughs Wellcome Fund and the Packard Foundation.

Attached Files

Accepted Version - nihms948739.pdf

Files

nihms948739.pdf

Files (673.7 kB)

Name Size Download all
md5:5c2cc5398218529bdb95580d56a0b4e1
673.7 kB Preview Download

Additional details

Identifiers

PMCID
PMC6289519
Eprint ID
84956
DOI
10.1002/aic.16138
Resolver ID
CaltechAUTHORS:20180226-134658661

Related works

Describes
10.1002/aic.16138 (DOI)

Funding

NIH
R01-EB018975
Human Frontier Science Program
RGP0050
NSF Graduate Research Fellowship
DGE-1144469
NIH
Natural Sciences and Engineering Research Council of Canada (NSERC)
Heritage Medical Research Institute
Pew Charitable Trust
Sontag Foundation
Burroughs Wellcome Fund
David and Lucile Packard Foundation

Dates

Created
2018-02-26
Created from EPrint's datestamp field
Updated
2022-03-17
Created from EPrint's last_modified field

Caltech Custom Metadata

Caltech groups
Heritage Medical Research Institute